✦ LIBER ✦

A phase II trial of pemetrexed in combination with carboplatin in patients with recurrent ovarian or primary peritoneal cancer

✍ Scribed by Jalid Sehouli; Ana Maria Alvarez; Shokoufeh Manouchehrpour; Prafull Ghatage; Cezary Szczylik; Annamaria Zimmermann; Thomas Bauknecht; Katherine Y. Look; Gultan Oskay-Öezcelik

Book ID: 113963444
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 184 KB
Volume: 124
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2011.09.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of pemetrexed and carbopl

Phase II trial of pemetrexed and carboplatin in platinum-sensitive recurrent ovarian, fallopian tube, and primary peritoneal cancer

✍ Van Arsdale, A.; Einstein, M.H.; Brewer, M.A.; Timmins, P.F.; Wright, J.D.; Leis 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB

A phase-I trial of pemetrexed plus carbo

A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer

✍ Jalid Sehouli; Oumar Camara; Sven Mahner; Thomas Bauknecht; Werner Lichtenegger; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 180 KB

Randomized phase II trial of sorafenib a

Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer

✍ Schwandt, Anita; Gruenigen, Vivian E.; Wenham, Robert M.; Frasure, Heidi; Eaton, 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 374 KB

A phase II clinical trial of pegylated l

A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer

✍ Marcela G. del Carmen; John Micha; Laurie Small; Daron G. Street; Anil Londhe; T 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 254 KB

Whole-body hyperthermia (WBH) in combina

Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer — A phase II study

✍ Akin Atmaca; Salah-Eddin Al-Batran; Antje Neumann; Yvonne Kolassa; Dirk Jäger; A 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Phase II evaluation of a 3-day infusion

Phase II evaluation of a 3-day infusion of topotecan in patients with recurrent ovarian or primary peritoneal cancer

✍ Thomas J. Herzog; Matthew A. Powell; Janet S. Rader; Randall Gibb; David G. Mutc 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 127 KB